Agilent Technologies, Inc.
ANYSEHealthcare● Active
$132.69
$-2.75(-2.03%)
Market Cap$37.5B
P/E Ratio—
52W High$160.27
52W Low$108.35
Agilent Technologies, Inc.（A）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · A · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-10 | 2024-10 | 2023-10 | 2022-10 | 2021-10 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $1.79B | $1.33B | $1.59B | $1.05B | $1.57B |
| Net Receivables | $1.49B | $1.32B | $1.29B | $1.41B | $1.17B |
| Inventory | $1.02B | $0.99B | $1.03B | $1.04B | $0.83B |
| Total Current Assets | $4.59B | $3.96B | $4.19B | $3.78B | $3.80B |
| PP&E Net | $2.02B | $1.96B | $1.42B | $1.10B | $0.94B |
| Goodwill | $4.47B | $4.47B | $3.96B | $3.95B | $3.98B |
| Intangible Assets | $0.45B | $0.55B | $0.47B | $0.82B | $0.98B |
| Total Assets | $12.73B | $11.85B | $10.76B | $10.53B | $10.71B |
| Liabilities | |||||
| Short-Term Debt | $0.30B | $0.04B | $0.00B | $0.04B | $0.00B |
| Accounts Payable | $0.57B | $0.54B | $0.42B | $0.58B | $0.45B |
| Total Current Liabilities | $2.35B | $1.90B | $1.60B | $1.86B | $1.71B |
| Long-Term Debt | $3.05B | $3.35B | $2.73B | $2.73B | $2.73B |
| Total Liabilities | $5.99B | $5.95B | $4.92B | $5.23B | $5.32B |
| Stockholders Equity | |||||
| Retained Earnings | $1.39B | $0.75B | $0.78B | $0.32B | $0.35B |
| Total Stockholders Equity | $6.74B | $5.90B | $5.84B | $5.30B | $5.39B |
| Total Liab & Equity(computed) | $12.73B | $11.85B | $10.76B | $10.53B | $10.71B |
| Debt Summary | |||||
| Total Debt | $3.35B | $3.57B | $2.73B | $2.77B | $2.73B |
| Net Debt | $1.56B | $2.25B | $1.15B | $1.72B | $1.25B |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Agilent Technologies, Inc.
关于Agilent Technologies, Inc.（A）资产负债表
Agilent Technologies, Inc.总资产$12.73B，现金及短期投资$1.79B，总负债$5.99B，总债务$3.35B，股东权益$6.74B。
常见问题
A · 4 问Agilent Technologies, Inc.总债务$3.35B，净债务$1.56B。
A total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10